TradingMarkets 7 Stocks You Need To Know For Friday

The New England Journal of Medicine said a study financed by Merck
(
MRK |
Quote |
Chart |
News |
PowerRating) could have fudged data. A third Vioxx trial just went to the jury. The
stock traded lower after hours.

In its mid-quarter update, Intel
(
INTC |
Quote |
Chart |
News |
PowerRating) lowered the high end of
its guidance and sees Q4 revenues between $10.4 -10.6 billion. The stock traded
lower after hours.

Furniture Brands
(
FBN |
Quote |
Chart |
News |
PowerRating) guided higher

KH Homes
(
KBH |
Quote |
Chart |
News |
PowerRating) raised its dividend 33% to an annual $1.00/share.

Credence
(
CMOS |
Quote |
Chart |
News |
PowerRating) missed by 0.02 and guided lower.

Dendrite
(
DRTE |
Quote |
Chart |
News |
PowerRating) guided Q4 lower and now sees Q4 revenues of
$106-$108 million vs. the $118 million consensus.

Zila
(
ZILA |
Quote |
Chart |
News |
PowerRating) missed by  0.04, on lighter than expected
revenues.

Brice Wightman

Be sure to vote for
TradingMarkets in the 13th Annual
Stocks & Commodities
2006 Readers’ Choice Awards